The World Health Organisation (WHO), yesterday endorsed dexamethasone as ‘cure’ drug for saving lives of critically ill coronavirus disease (COVID-19) patients.
Dexamethasone is a breakthrough in the global race to discover a safe and effective drug for treatment and prevention of the disease.
The WHO welcomed the initial clinical trial results from the United Kingdom (UK) that showed dexamethasone, a corticosteroid, can be life-saving for patients who are critically ill with COVID-19.
According to preliminary findings shared with WHO, for patients on ventilators, the treatment was shown to reduce mortality by about one third.
Also, for patients requiring only oxygen, mortality was cut by about one fifth. The benefit was only seen in patients seriously ill with COVID-19 and was not observed in patients with milder disease.
WHO Director-General, Dr. Tedros Adhanom Ghebreyesus, said: “This is the first treatment to be shown to reduce mortality in patients with COVID-19 requiring oxygen or ventilator support.